Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.7b00787
Abstract: Zirconium-89 is an emerging radionuclide for positron emission tomography (PET) especially for biomolecules with slow pharmacokinetics as due to its longer half-life, in comparison to fluorine-18 and gallium-68, imaging at late time points is feasible.… read more here.
Keywords: dfo zegfr; 2377 affibody; zegfr 2377; affibody bioconjugates ... See more keywords